% Expired Patents = 50.0

EPO Patents = 3

Forward Citations = 6

Loading Chart...

4 inventors (with patents filed for the assignee):

Bruce Edward Markham (4 out of 4 patents)

Rainer Ng (2 out of 2 patents)

Joseph M Metzger (2 out of 8 patents)

4. Lorraine E Reeve (2 out of 31 patents)

4 patents: Sort by Forward Citations

1. 9155758 - Treatment of chronic progressive heart failure (2015-10-13),

2. 9107940 - Compositions and methods for treating and preventing skeletal muscle deficiencies (2015-08-18),

3. 8852568 - Compositions and methods for treating and preventing skeletal muscle deficiencies (2014-10-07),

4. 8372387 - Compositions and methods for the treatment of heart failure (2013-02-12),

Phrixus Pharmaceuticals is a biopharmaceutical company focused on developing therapeutic solutions for rare and devastating diseases. Their lead product candidate, Carmeseal-MD, is being developed for the treatment of Duchenne muscular dystrophy, a progressive muscle-wasting disease. The company is dedicated to improving the lives of patients with unmet medical needs through innovative research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

4 Patents

#156 in Ann Arbor, MI

#2,020 in Michigan

#60,515 in US

Ann Arbor, MI, United States of America

Phrixus Pharmaceuticals, Inc.

Forward Citations = 6

4 inventors:

Bruce Edward Markham (4 out of 4 patents)

Rainer Ng (2 out of 2 patents)

Joseph M Metzger (2 out of 8 patents)

4. Lorraine E Reeve (2 out of 31 patents)

Please report any incorrect information to [email protected]

3 patents (EPO):

Please report any incorrect information to [email protected]